CCO Treatment Updates

Treatment Advances in Multiple Myeloma: Management of Challenging Clinical Scenarios

Novel Therapies and Risk-Stratified Approaches for Challenging Patients With Multiple Myeloma

Module 1 of 1

Faculty:

Robert Z. Orlowski, MD, PhDAisha Hasan, MD
  • Robert Z. Orlowski, MD, PhD
  • Aisha Hasan, MD

CME CREDIT INFORMATION

Release Date: 05/15/07

Expiration Date: 05/14/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status
Begin the Module

Aisha Hasan, MD, and Robert Z. Orlowski, MD, PhD, provide a concise overview of emerging therapeutic agents and combinations of agents for myeloma as well as prognostic factors for patients with high-risk disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss treatment options for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation
  • List risk factors, including specific cytogenetic abnormalities, that adversely affect prognosis in patients with multiple myeloma
  • Describe the significance of renal impairment as a determinant of treatment course in patients with multiple myeloma

Interactive Case Challenges

Treatment of Multiple Myeloma in a 63-Year-Old Male With Renal Insufficiency

Faculty:

Sagar Lonial, MD
  • Sagar Lonial, MD

CME CREDIT INFORMATION

Release Date: 05/15/07

Expiration Date: 05/14/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the Case Challenge

Test your ability to manage a patient with renal insufficiency and stage III disease by International Staging System criteria.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Outline appropriate staging and classification of multiple myeloma
  • Discuss recent clinical developments in the treatment of newly diagnosed patients with multiple myeloma
  • Describe the significance of renal function in determining the appropriate course of therapy for multiple myeloma

Management of an Older Multiple Myeloma Patient With Extensive Bony Disease and Multiple Cytogenetic Abnormalities

Faculty:

Paul G. Richardson, MD
  • Paul G. Richardson, MD

CME CREDIT INFORMATION

Release Date: 06/13/07

Expiration Date: 06/12/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status
Begin the Case Challenge

In this case, Paul G. Richardson, MD, presents treatment options for an elderly patient who initially presented with a 2- to 3-month history of persistent low-back pain, chest wall discomfort, and fatigue.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe appropriate treatment options for an elderly patient with multiple myeloma and high-risk characteristics including adverse cytogenetics
  • Discuss management strategies for addressing hematologic toxicity associated with use of novel myeloma therapies
  • Review strategies for managing disease recurrence in an elderly patient with multiple myeloma previously treated with a bortezomib-containing regimen
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.